Prostate Cancer Clinical Trial
ExoDx Prostate Evaluation in Active Surveillance Patient Population
The current trial seeks to evaluate the role of the ExoDx Prostate test in men with low and favorable intermediate prostate cancer undergoing an active surveillance regimen.
Male, 45+ years of age diagnosed with low-grade or favorable-intermediate prostate cancer and on an active surveillance regimen
Clinical symptoms of urinary tract infection at time of enrollment.
History of invasive treatment for benign prostatic hypertrophy with in 6 months of enrollment.
Known hepatitis or HIV
History of concurrent renal/bladder tumors
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
How clear is this clinincal trial information?
Introducing, the Journey Bar
Use this bar to access information about the steps in your cancer journey.